Metastatic cutaneous apocrine carcinoma of the axilla successfully treated using systemic chemotherapy with i.v. epirubicin and cyclophosphamide followed by oral fluorinated pyrimidine

1 Kowal-Vern A, Criswell BK. Burn scar neoplasms: a literature review and statistical analysis. Burns 2005; 31: 403–413. 2 Angervall L, Kindblom LG, Merck C. Myxofibrosarcoma. A study of 30 casesActa Pathol Microbiol Scand A 1977; 85A: 127–140. 3 Weiss SW, Enzinger FM. Myxoid variant of malignant fibrous histiocytoma. Cancer 1977; 39: 1672–1685. 4 Mentzel T, Calonje E, Wadden C et al. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol 1996; 20: 391–405. 5 Kim GI, Lee JH, Kim HK, Park SH, Kim CH. Malignant fibrous histiocytoma in a chronic burn scar: a rare case report and review of the literature. Burns 2004; 30: 742–745.

[1]  M. Mizuashi,et al.  Successful treatment of HER-2-positive metastatic apocrine carcinoma of the skin with lapatinib and capecitabine. , 2012, Acta dermato-venereologica.

[2]  D. Staffenberg,et al.  Metastatic apocrine carcinoma of the scalp: prolonged response to systemic chemotherapy. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Rie Takada,et al.  Differential expression of mucin core proteins and keratins in apocrine carcinoma, extramammary Paget’s disease and apocrine nevus , 2009, Journal of cutaneous pathology.

[4]  F. Cavalli,et al.  Axillary apocrine carcinoma with brain metastases. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  A. Kowal-Vern,et al.  Burn scar neoplasms: a literature review and statistical analysis. , 2005, Burns : journal of the International Society for Burn Injuries.

[6]  J. H. Lee,et al.  Malignant fibrous histiocytoma in a chronic burn scar: a rare case report and review of the literature. , 2004, Burns : journal of the International Society for Burn Injuries.

[7]  W. Goebel,et al.  Differential expression of , 1999 .

[8]  M. A. Smith,et al.  Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. , 1996, The American journal of surgical pathology.

[9]  D. Haagensen,et al.  Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. , 1983, The American journal of pathology.

[10]  S. Weiss,et al.  Myxoid variant of malignant fibrous histiocytoma , 1977, Cancer.